Mawallafi: Gregory Harris
Ranar Halitta: 10 Afrilu 2021
Sabuntawa: 18 Nuwamba 2024
Anonim
L-Триптофан и 5-HTP что это? Как принимать от депрессии, бессонницы и для похудения?
Video: L-Триптофан и 5-HTP что это? Как принимать от депрессии, бессонницы и для похудения?

Wadatacce

5-HTP (5-hydroxytryptophan) wani sinadari ne wanda aka samar dashi daga ginin ginin sunadarin L-tryptophan. Hakanan ana samar da shi ta kasuwanci daga tsirrai na tsire-tsire na Afirka da aka sani da Griffonia simplicifolia.

Ana amfani da 5-HTP don rikicewar bacci kamar rashin bacci, damuwa, damuwa, da sauran yanayi, amma babu wata kyakkyawar shaidar kimiyya da zata tallafawa mafi yawan waɗannan amfani.

Magunguna na Compwararren Bayanan Bayanai ƙimar tasiri bisa ga shaidar kimiyya bisa ga mizani mai zuwa: Inganci, Mai yuwuwa Mai Yiwuwa, Yiwuwar Tasiri, Yiwuwar Mara Inganci, Mai yiwuwa Mara Inganci, Mara Inganci, da suarancin Shaida don Rate.

Effectivenessimar tasiri don 5-HTP sune kamar haka:

Yiwuwar tasiri ga ...

  • Bacin rai. Shan 5-HTP da baki alama na inganta alamun rashin damuwa a cikin wasu mutane. Wasu bincike na asibiti sun nuna cewa shan 5-HTP da baki na iya zama mai amfani kamar wasu takaddun antidepressant don inganta cututtukan ciki. A yawancin karatu, an ɗauki 150-800 MG kowace rana na 5-HTP. A wasu lokuta, an yi amfani da allurai mafi girma.

Zai yuwu bashi da tasiri ga ...

  • Rashin ciwo. Wasu bincike sun nuna cewa bada 5-HTP ga jarirai masu fama da cutar Down syndrome na iya inganta tsoka da aiki. Sauran bincike sun nuna cewa baya inganta tsoka ko ci gaba lokacin da aka ɗauke shi tun yana jariri har zuwa shekaru 3-4. Bincike ya kuma nuna cewa shan 5-HTP tare da magunguna na al'ada na inganta ci gaba, ƙwarewar zamantakewa, ko ƙwarewar harshe.

Evidencearancin shaida don kimanta inganci don ...

  • Wani nau'in tashin hankali wanda aka yiwa alama ta maimaita tunani da maimaita hali (rikice-rikice-rikice ko OCD). Binciken farko ya nuna cewa shan 5-HTP tare da kwayar cutar kwayar cutar ta fluoxetine (Prozac) na makonni 12 na iya inganta wasu alamun OCD.
  • Rashin amfani da giya. Binciken farko ya nuna cewa shan 5-HTP tare da D-phenylalanine da L-glutamine na tsawon kwanaki 40 na iya rage alamun shan giya. Koyaya, shan 5-HTP tare da carbidopa kowace shekara har tsawon shekara ɗaya da alama ba zai taimaka wa mutane su daina shan giya ba. Tasirin 5-HTP kadai don shaye-shaye bai bayyana ba.
  • Alzheimer cuta. Binciken farko ya nuna cewa shan 5-HTP ta baki ba ya taimakawa alamomin cutar Alzheimer.
  • Tashin hankali. Shaida akan tasirin 5-HTP don damuwa ba bayyananne bane. Binciken farko ya nuna cewa shan 25-150 MG na 5-HTP ta baki kowace rana tare da carbidopa alama na rage alamun bayyanar tashin hankali a cikin mutanen da ke fama da matsalar damuwa. Koyaya, sauran binciken farko sun nuna cewa shan ƙwayoyi masu yawa na 5-HTP, 225 MG kowace rana ko ƙari, da alama yana ƙara damuwa. Hakanan, shan MG 60 na 5-HTP kowace rana ta cikin jijiya baya rage damuwa ga mutanen da ke fama da matsalar tsoro.
  • Lalacewar Brain da ke Shafar Motsa Jiki (cerebellar ataxia). Shaida akan amfani da 5-HTP na cerebellar ataxia ba bayyananne bane. Shaidun farko sun nuna cewa shan 5 mg / kg na 5-HTP yau da kullun tsawon watanni 4 na iya rage lalacewar tsarin damuwa. Koyaya, wasu bincike sun nuna cewa shan 5-HTP kowace rana har zuwa shekara ɗaya baya inganta alamun bayyanar ataxia.
  • Fibromyalgia. Binciken farko ya nuna cewa shan 100 MG na 5-HTP ta baki sau uku kowace rana don kwanaki 30-90 na iya inganta ciwo, taushi, bacci, damuwa, gajiya, da taurin kai a cikin mutanen da ke fama da fibromyalgia.
  • Alamomin rashin al'ada. Binciken farko ya nuna cewa shan MG 150 na 5-HTP kowace rana tsawon makonni 4 baya rage walƙiya mai zafi a cikin matan da suka gama aure.
  • Ciwon mara. Shaida akan tasirin 5-HTP don rigakafi ko maganin ƙaura a cikin manya ba bayyananne bane. Wasu nazarin suna nuna cewa shan 5-HTP kowace rana baya rage ƙaura, yayin da wasu nazarin ke nuna cewa zai iya zama fa'ida kamar magungunan ƙwayoyi. 5-HTP ba ze rage ƙaura a cikin yara ba.
  • Kiba. Binciken farko ya nuna cewa shan 5-HTP na iya taimakawa rage yawan ci, yawan cin abinci mai amfani da caloric, da kuma nauyi a cikin masu kiba. Sauran bincike sun nuna cewa amfani da takamaiman bakin feshi mai dauke da 5-HTP da sauran ruwan magani (5-HTP-Nat Exts, Medestea Biotech Sip, Torino, Italia) na tsawon makonni 4 yana kara rage nauyi da kimanin kashi 41% a cikin mata masu matsakaicin nauyi.
  • Saukewa daga heroin, morphine, da sauran magungunan opioid. Binciken farko ya nuna cewa shan 200 MG na 5-HTP kowace rana don kwanaki 6 tare da tyrosine, phosphatidylcholine, da L-glutamine, na iya rage rashin bacci da kuma kawar da alamun bayyanar cutar don murmurewa daga jarabar heroin.
  • Cutar Parkinson. Binciken farko ya nuna cewa shan 100-150 MG na 5-HTP ta baki kowace rana tare da magunguna na yau da kullun kamar yana rage girgiza, amma waɗannan fa'idodin suna ci gaba har zuwa watanni 5. Sauran bincike na farko sun nuna cewa shan MG 50 na 5-HTP yau da kullun na iya rage alamomin rikicewar motsi daga levodopa miyagun ƙwayoyi, da kuma alamun ɓacin rai, a cikin mutanen da ke da cutar Parkinson. Amma shan manyan allurai na 5-HTP, 275-1500 MG kowace rana, tare da carbidopa na iya ƙara ɓarke ​​wasu alamun.
  • Tashin hankali. Binciken farko ya nuna cewa shan 100 mg na 5-HTP sau uku a rana tsawon sati 8 baya rage zafi ko tsawon ciwon kai.
  • Rashin hankali-raunin rashin hankali (ADHD).
  • Rashin bacci.
  • Ciwon dysphoric na premenstrual (PMDD).
  • Ciwon premenstrual (PMS).
  • Ramsey-Hunt ciwo.
  • Sauran yanayi.
Ana buƙatar ƙarin shaida don kimanta tasirin 5-HTP don waɗannan amfani.

5-HTP yana aiki a cikin kwakwalwa da tsarin kulawa ta tsakiya ta hanyar haɓaka samar da sinadarin serotonin. Serotonin na iya shafar bacci, ci, zafin jiki, halayyar jima'i, da jin zafi. Tunda 5-HTP yana haɓaka kwayar serotonin, ana amfani dashi don cututtuka da yawa inda serotonin yayi imani yana taka muhimmiyar rawa gami da ɓacin rai, rashin bacci, kiba, da sauran yanayi.

Lokacin shan ta bakin: 5-HTP shine MALAM LAFIYA lokacin shan ta bakin da ya dace. An yi amfani dashi lafiya a cikin allurai har zuwa 400 MG kowace rana har zuwa shekara guda. Amma wasu mutanen da suka sha 5-HTP sun sami wani yanayin da ake kira eosinophilia-myalgia syndrome (EMS). EMS wani mummunan yanayi ne wanda ya shafi tsananin taushin tsoka (myalgia) da rashin daidaito na jini (eosinophilia). Wasu mutane suna tunanin EMS na iya haifar da haɗarin haɗari ko gurɓata a cikin wasu kayan 5-HTP. Amma babu isasshen shaidar kimiyya don sanin idan EMS ya faru ne ta 5-HTP, gurɓataccen abu, ko kuma wani abu. Har sai an san da yawa, ya kamata a yi amfani da 5-HTP a tsanake.

Sauran illolin dake tattare da cutar 5-HTP sun hada da zafin rai, ciwon ciki, tashin zuciya, amai, gudawa, yawan bacci, matsalolin jima'i, da matsalolin tsoka.

5-HTP shine YIWU KA KIYAYE lokacin da aka sha baki a manyan allurai. Allura daga gram 6-10 a kowace rana ana danganta ta da matsalolin ciki mai tsanani da kuma tsoka.

Kariya & Gargaɗi na Musamman:

Ciki da shan nono: Babu isasshen bayani tabbatacce don sanin ko 5-HTP yana da aminci don amfani yayin ciki ko shayarwa. Kasance a gefen aminci ka guji amfani.

Yara: 5-HTP shine MALAM LAFIYA lokacin da aka sha baki sosai. An yi amfani da allurai har zuwa 5 MG / kg kowace rana cikin aminci har zuwa shekaru 3 a cikin jarirai da yara har zuwa shekaru 12. Kamar yadda yake tare da manya, akwai kuma damuwa game da yuwuwar cutar eosinophilia-myalgia syndrome (EMS) a cikin yara, mummunan yanayi wanda ya shafi tsananin taushin tsoka (myalgia) da rashin daidaiton jini (eosinophilia).

Tiyata: 5-HTP na iya shafar wani sinadarin kwakwalwa da ake kira serotonin. Wasu kwayoyi da ake gudanarwa yayin aikin tiyata na iya shafar serotonin. Shan 5-HTP kafin tiyata na iya haifar da kwayar serotonin a cikin kwakwalwa sosai kuma hakan na iya haifar da mummunar illa gami da matsalolin zuciya, rawar jiki, da damuwa. Faɗa wa marasa lafiya su daina shan 5-HTP aƙalla makonni 2 kafin aikin tiyata.

Manjo
Kada ku ɗauki wannan haɗin.
Magunguna don baƙin ciki (MAOIs)
5-HTP yana kara wani sinadari a kwakwalwa mai suna serotonin. Wasu magunguna da ake amfani dasu don baƙin ciki suma suna haɓaka serotonin. Shan 5-HTP tare da waɗannan magungunan da aka yi amfani da su don baƙin ciki na iya ƙara serotonin sosai. Wannan na iya haifar da mummunan sakamako ciki har da tsananin ciwon kai, matsalolin zuciya, rawar jiki, rikicewa, da damuwa.

Wasu daga cikin waɗannan magungunan da ake amfani dasu don ɓacin rai sun haɗa da phenelzine (Nardil), tranylcypromine (Parnate), da sauransu.
Matsakaici
Yi hankali da wannan haɗin.
Carbidopa (Lodosyn)
5-HTP na iya shafar kwakwalwa. Carbidopa (Lodosyn) na iya shafar ƙwaƙwalwa. Shan 5-HTP tare da carbidopa na iya kara haɗarin mummunar illa mai haɗari ciki har da saurin magana, damuwa, tashin hankali, da sauransu.
Magungunan kwantar da hankali (CNS depressants)
5-HTP na iya haifar da bacci da bacci. Ana kiran magungunan da ke haifar da bacci. Shan 5-HTP tare da magungunan kwantar da hankali na iya haifar da yawan bacci.

Wasu magunguna masu kwantar da hankali sun haɗa da clonazepam (Klonopin), lorazepam (Ativan), phenobarbital (Donnatal), zolpidem (Ambien), da sauransu.
Magungunan serotonergic
5-HTP na iya kara wani sinadari a kwakwalwa wanda ake kira serotonin. Wasu magunguna ma suna ƙara serotonin. Shan 5-HTP tare da waɗannan magunguna na iya ƙara serotonin sosai. Wannan na iya haifar da mummunar illa ciki har da tsananin ciwon kai, matsalolin zuciya, rawar jiki, rikicewa, da damuwa.

Wasu daga cikin wadannan magungunan sun hada da fluoxetine (Prozac), paroxetine (Paxil), sertraline (Zoloft), amitriptyline (Elavil), clomipramine (Anafranil), imipramine (Tofranil), sumatriptan (Imitrex), zolmitriptan (Zomig), rizatriptan (Maxz) methadone (Dolophine), tramadol (Ultram), da sauran su.
Ganye da kari tare da kayan haɓaka
5-HTP na iya haifar da bacci ko bacci. Amfani da shi tare da sauran ganyayyaki da kari waɗanda ke da tasiri iri ɗaya na iya haifar da yawan bacci. Wasu daga cikin wadannan ganyayyaki da kari sun hada da calamus, California poppy, catnip, hops, Jamaican dogwood, kava, St. John’s wort, skullcap, valerian, yerba mansa, da sauransu.
Ganye da kari tare da abubuwan serotonergic
5-HTP yana kara sinadarin kwakwalwa mai suna serotonin. Shan 5-HTP tare da sauran ganyayyaki da kari wanda ke kara serotonin na iya haifar da cutar serotonin da yawa kuma yana haifar da illa tare da matsalolin zuciya, girgiza da damuwa. Sauran ganye da kari wadanda ke kara yawan kwayar serotonin sun hada da Hawaiian baby woodrose, L-tryptophan, S-adenosylmethionine (SAMe), da kuma St. John’s wort.
Babu sanannun hulɗa da abinci.
An yi nazarin ƙwayoyi masu zuwa a cikin binciken kimiyya: MAGABATA

DA BAKI:
  • Don damuwa: Mafi yawanci, ana ɗaukar 150-800 MG kowace rana don makonni 2-6. Waɗannan allurai wasu lokuta ana raba su kuma ana gudanar dasu azaman 50 MG zuwa 100 MG sau uku a rana. Wani lokaci maganin yana farawa low kuma yana ƙaruwa koyaushe kowane mako 1-2 har sai an cimma kashi mai mahimmanci. Kadan da yawa, ana amfani da allurai mafi girma. A cikin binciken daya, an ƙara yawan nauyin har zuwa 3 grams kowace rana.
2-Amino-3- (5-Hydroxy-1H-Indol-3-yl) Propanoic Acid, 5 Hydroxy-Tryptophan, 5 Hydroxy-Tryptophane, 5-Hydroxytryptophan, 5-Hydroxytryptophane, 5-Hydroxy L-Tryptophan, 5-Hydroxy L-Tryptophane, 5-Hydroxy Tryptophan, 5-L-Hydroxytryptophan, L-5 HTP, L-5-Hydroxytryptophan, L-5-Hydroxytryptophane, Oxitriptan.

Don ƙarin koyo game da yadda aka rubuta wannan labarin, da fatan za a duba Magunguna na Compwararren Bayanan Bayanai hanya.


  1. Meloni M, Puligheddu M, Sanna F, et al. Inganci da amincin 5-Hydroxytryptophan akan levodopa wanda ya haifar da rikitarwa na motsa jiki a cututtukan Parkinson: Binciken farko. J Neurol Sci. 2020; 415: 116869. Duba m.
  2. Yousefzadeh F, Sahebolzamani E, Sadri A, et al. 5-Hydroxytryptophan a matsayin adjuvant far a lura da matsakaici zuwa mai tsananin rikice-rikice-rikice-rikice: fitina bazuwar makafi biyu tare da kulawar wuribo. Int Clin Psychopharmacol. 2020; 35: 254-262. Duba m.
  3. Javelle F, Lampit A, Bloch W, Häussermann P, Johnson SL, Zimmer P. Sakamakon 5-hydroxytryptophan akan nau'ikan nau'ikan baƙin ciki: nazari na yau da kullun da ƙididdigar abubuwa. Nutr Rev 2020; 78: 77-88. Duba m.
  4. Meloni M, Puligheddu M, Carta M, Cannas A, Figorilli M, Defazio G. Inganci da amincin 5-hydroxytryptophan kan damuwa da rashin jin daɗi a cikin cutar ta Parkinson: binciken farko. Eur J Neurol 2020; 27: 779-786. Duba m.
  5. Israelyan N, Del Colle A, Li Z, et al. Illolin Serotonin da Slow-Saki 5-Hydroxytryptophan akan Motsawar Gastrointestinal a cikin Mouse Model of Depression. Gastroenterology. 2019; 157: 507-521.e4. Duba m.
  6. Michelson D, Shafin SW, Casey R, et al. Cutar rashin lafiyar eosinophilia-myaligia da ke da alaƙa da haɗuwa da l-5-hydroxytryptophan. J Rheumatol 1994; 21: 2261-5. Duba m.
  7. Lemaire PA, Adosraku RK.Hanyar HPLC don gwajin kai tsaye na farkon serotonin, 5-hydroxytrophan, a cikin tsabawar Griffonia simplicifolia. Phytochem Anal 2002; 13: 333-7. Duba m.
  8. Rondanelli M, Opizzi A, Faliva M, Bucci M, Perna S. Dangantaka tsakanin shan 5-hydroxytryptophan daga hadadden abinci, ta hanyar cire Griffonia simplicifolia, da kuma tasirin jin ƙai a cikin mata masu kiba bayan maganin feshi na baka. Ci Rashin nauyi 2012; 17: e22-8. Duba m.
  9. Pardo JV. Mania tana bin ƙarin hydroxytryptophan zuwa mai hana monoamine oxidase. Gen Hosp Zuciya 2012; 34: 102.e13-4.
  10. Chen D, Liu Y, He W, Wang H, Wang Z. Neurotransmitter-precursor-supplement intervention don masu lalata heroin addicts. J Huazhong Univ Sci Technolog Med Sci 2012; 32: 422-7.
  11. Gendle MH, Matasa EL, Romano AC. Hanyoyin 5-hydroxytryptophan na baka akan daidaitaccen aikin tsarawa: fahimta game da yiwuwar hulɗar dopamine / serotonin a cikin gaba. Hum Psychopharmacol 2013; 28: 270-3.
  12. Kwamitin Ba da Shawara kan Ba ​​da Shawarwari kan Magungunan Kula da Magunguna na Abincin da Magunguna na Amurka na Yuni 17-18, 2015. Akwai a: www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/drugs/pharmacycompoundingadvisorycommittee/ucm455276.pdf (an isa ga 8/21/15).
  13. Cibiyar Abinci da Magunguna ta Amurka. Bayyana magungunan marayu da amincewa. Akwai a: www.accessdata.fda.gov/scripts/opdlisting/oopd/index.cfm (an isa ga 8/20/2015).
  14. Das YT, Bagchi M, Bagchi D, Preuss HG. Tsaro na 5-hydroxy-L-tryptophan. Littafin Toxicol 2004; 150: 111-22. Duba m.
  15. Weise P, Koch R, Shaw KN, Rosenfeld MJ. Yin amfani da 5-HTP a cikin maganin rashin lafiyar Down's syndrome. Ilimin yara 1974; 54165-8. Duba m.
  16. Bazelon M, Paine RS, Cowie VA, et al. Rushewar hypotonia a cikin jarirai masu cutar Down's syndrome ta hanyar gudanarwar 5-hydroxytryptophan. Lancet 1967; 1: 1130-3. Duba m.
  17. Sano I. Far na rashin damuwa tare da L-5-hydroxytryptophan (L-5-HTP). Zuciyar et Neurologia Japonicas 1972; 74: 584.
  18. Klein P, Lees A, da Stern G. Sakamakon 5-hydroxytryptophan na yau da kullun a cikin rashin daidaito na rashin motsa jiki da daidaito da kuma cikin wasu cututtukan jijiyoyin jiki. Adv Neurol 1986; 45: 603-604.
  19. VanPraag, H. M. da Korf, J. 5-Hydroxytryptophan a matsayin antidepressant: predicimar tsinkayen gwajin probenecid. Psychopharmacol. Shanu. 1972; 8: 34-35.
  20. Sicuteri F. 5-hydroxytryptophan a cikin prophylaxis na ƙaura. Sadarwar Nazarin Magunguna na 1972; 4: 213-218.
  21. Rosano Burgio, F., Borgatti, R., Scarabello, E., da Lanzi, G. Ciwon kai a cikin yara da matasa. Ci gaban Taron Taron Kasa da Kasa na Farko kan Ciwon Kai a Yara da Matasa. 1989; 339-47.
  22. Mathew NT. 5-hydroxytryptophan a cikin prophylaxis na migraine: binciken makafi biyu. Ciwon kai 1978; 18: 111.
  23. De Benedittis G, Massei R. 5-HT masu tsinkaye a cikin maganin ƙaura na ƙaura: nazarin makafi mai makafi biyu tare da L-5-hydroxytryptophan. Clin J Zafin rai 1986; 2: 123-129.
  24. Wyatt, R.J, Vaughan, T., Kaplan, J., Galanter, M., da Green, R. 5-Hydroxytryptophan da ci gaban rashin hankali. A cikin: Barchas J da Usdin E. Serotonin da Halayyar. New York: Acedemic Latsa; 1973.
  25. Brodie HKH, Sack R, da Siever L. Nazarin asibiti na L-5-hydroxytryptophan a cikin damuwa. A cikin: Barchas J da Usdin E. Serotonin da halayya. New York: Cibiyar Nazarin Ilimi; 1973.
  26. Auffret, M., Comte, H., da Bene, J. Eosinophilia-myalgia ciwo wanda L-5 hydroxytryptophane ya haifar: game da abubuwa uku. Asusun Clinic Pharmacol 2013; Gudanar da 1: hoton P2-204.
  27. Cangiano C, Laviano A, Del Ben M, et al. Hanyoyin 5-hydroxy-tryptophan na baka akan cin kuzari da zaɓi na macronutrient a cikin marasa lafiyar insulin masu dogaro da insulin. Int J Obes Relat Metab Disord 1998; 22: 648-54. Duba m.
  28. Ju, C. Y. da Tsai, C. T. Serotonergic hanyoyin da ke cikin kawar da ciyarwa ta hanyar 5-HTP a cikin berayen. Chin J Physiol 1995; 38: 235-240. Duba m.
  29. Pranzatelli, M. R., Tate, E., Galvan, I., da Wheeler, A. Gwajin da aka gudanar na 5-hydroxy-L-tryptophan don ataxia a cikin ci gaban cutar sankarau. Clin Neurol. Neurosurg. 1996; 98: 161-164. Duba m.
  30. Frith, C. D., Johnston, E. C., Joseph, M. H., Powell, R.J, da Watts, R. W. Gwajin makafi biyu na asibiti na 5-hydroxytryptophan a game da cutar Lesch-Nyhan. J Neurol Neurosurg. Likitan zuciya 1976; 39: 656-662. Duba m.
  31. Bastard, J., Truelle, J. L., da Emile, J. [Tasirin 5 hydroxy-tryptophan a cutar ta Parkinson]. Nouv Presse Med 9-11-1976; 5: 1836-1837. Duba m.
  32. Trouillas P, Serratrice G, Laplane D, et al. Tsarin levorotatory na 5-hydroxytryptophan a cikin ataxia na Friedreich. Sakamakon binciken hadin gwiwa mai cike da makafi guda biyu. Jirgin Neurol 1995; 52: 456-60. Duba m.
  33. Wessel K, Hermsdörfer J, Deger K, et al. Nazarin makaho mai sau biyu tare da nau'ikan hydroxytryptophan a cikin marasa lafiya da cututtukan cututtukan zuciya. Jirgin Neurol 1995; 52: 451-5. Duba m.
  34. Alino, J. J., Gutierrez, J. L., da Iglesias, M. L. 5-Hydroxytryptophan (5-HTP) da MAOI (nialamide) a cikin maganin baƙin ciki. Nazari mai makafi biyu. Int Pharmacopsychiatry 1976; 11: 8-15. Duba m.
  35. Pranzatelli, M. R., Tate, E., Huang, Y., Haas, R.H, Bodensteiner, J., Ashwal, S., da Franz, D. Neuropharmacology na ci gaban cutar sankarar bargo: amsa ga 5- hydroxy-L-tryptophan. Farfadiya 1995; 36: 783-791. Duba m.
  36. Thomson, J., Rankin, H., Ashcroft, GW, Yates, CM, McQueen, JK, da Cummings, SW Maganin bakin ciki a aikace gabaɗaya: kwatankwacin L- tryptophan, amitriptyline, da haɗin L-tryptophan da amitriptyline tare da placebo. Psychol Med 1982; 12: 741-751. Duba m.
  37. Trouillas, P., Garde, A., Robert, JM, Renaud, B., Adeleine, P., Bard, J., da Brudon, F. [Rashin hankali na cututtukan cerebellar a ƙarƙashin dogon lokacin mulkin 5-HTP ko haɗin 5-HTP da benserazide. Lamura 26 da aka ƙididdige su kuma aka bi da su ta amfani da hanyoyin kwamfuta]. Rev Neurol. (Paris) 1982; 138: 415-435. Duba m.
  38. Thal, L. J., Sharpless, N. S., Wolfson, L., da Katzman, R. Jiyya na myoclonus tare da L-5-hydroxytryptophan da carbidopa: na asibiti, electrophysiological, da biochemical lura. Ann Neurol 1980; 7: 570-576. Duba m.
  39. van Hiele LJ. l-5-Hydroxytryptophan a cikin damuwa: farkon maye gurbin farfadowa a cikin tabin hankali? Maganin marasa lafiya 99 tare da 'maganin-juriya' damuwa. Neuropsychobiology 1980; 6: 230-40. Duba m.
  40. Magnussen, I. da Nielsen-Kudsk, F. Bioavailability da magunguna masu alaƙa da ke cikin mutum wanda aka gudanar da magana ta baki L-5-hydroxytryptophan a cikin tsayayyiyar ƙasa. Dokar Pharmacol Toxicol. (Copenh) 1980; 46: 257-262. Duba m.
  41. Trouillas, P., Garde, A., Robert, J. M., da Adeleine, P. [Ragewar ɗan adam ataxia a ƙarƙashin mulkin lokaci mai tsawo na 5-hydroxytryptophan]. CR Sances Acad Sci III 1-5-1981; 292: 119-122. Duba m.
  42. Pueschel SM, Reed RB, Cronk CE, Goldstein BI. 5-hydroxytryptophan da pyridoxine. Sakamakon su a cikin ƙananan yara masu fama da cutar rashin lafiya ta Down Am J Dis Yara 1980; 134: 838-44. Duba m.
  43. Longo G, Rudoi I, Iannuccelli M, Strinati R, Panizon F. [Jiyya na mahimman ciwon kai a cikin shekaru masu tasowa tare da L-5-HTP (ƙetare kan makafi biyu makafi da placebo)]. Pediatr Med Chir 1984; 6: 241-5. Duba m.
  44. Bono, G., Micieli, G., Sances, G., Calvani, M., da Nappi, G. L-5HTP magani a cikin ciwon kai na farko: ƙoƙari na gano asibiti na marasa lafiya. Cephalalgia 1984; 4: 159-165. Duba m.
  45. Quadbeck, H., Lehmann, E., da Tegeler, J. Kwatanta aikin maganin antidepressant na tryptophan, tryptophan / 5- hydroxytryptophan hade da nomifensine. Neuropsychobiology 1984; 11: 111-115. Duba m.
  46. van Praag, H. M. Don bincika yanayin aikin antidepressants: Cakuda 5-HTP / tyrosine a cikin ɓacin rai. Adv Biochem Psychopharmacol. 1984; 39: 301-314. Duba m.
  47. Trouillas P. Rashin hankali na cututtukan ƙwaƙwalwa tare da gudanar da mulki na dogon lokaci na 5-HTP ko haɗuwa da 5-HTP-benserazide: Sharuɗɗan 21 tare da alamun alamun da aka ƙididdige ta hanyar kwamfuta. Ital J Neurol Sci 1984; 5: 253-266. Duba m.
  48. van Praag, H. M. da de Haan, S. Chemoprophylaxis na damuwa. Attemptoƙarin kwatanta lithium da 5- hydroxytryptophan. Dokar Psychiatr.Scand Suppl 1981; 290: 191-201. Duba m.
  49. van Praag, H. da de Hann, S. Raunin rauni da 5-hydroxytryptophan prophylaxis. Ciwon magunguna Res. 1980; 3: 75-83. Duba m.
  50. Soulairac, A. [Ayyukan Hypnotic na mecloqualone. Kwatantawa da tasirin wuribo da secobarbital]. Gabatar da Mad 4-10-1971; 79: 817-818. Duba m.
  51. Chase, T. N., Ng, L. K., da Watanabe, cutar A. M. Parkinson. Gyarawa ta 5-hydroxytryptophan. Neurology 1972; 22: 479-484. Duba m.
  52. Wyatt, R.J, Vaughan, T., Galanter, M., Kaplan, J., da Green, R. Canje-canjen halayyar marasa lafiya masu cutar schizophrenic da aka ba L-5- hydroxytryptophan. Kimiyya 9-22-1972; 177: 1124-1126. Duba m.
  53. van Praag HM, Korf J, Dols LC, Schut T. Nazarin matukin jirgi game da tsinkayen ƙimar gwajin gwaji a aikace-aikacen 5-hydroxytryptophan azaman maganin rage damuwa. Psychopharmacologia 1972; 25: 14-21. Duba m.
  54. Zarcone, V., Kales, A., Scharf, M., Tan, T. L., Simmons, J. Q., da Dement, W. C. Maimaita shan shan 5-hydroxytryptophan. Tasiri kan halaye da tsarin bacci a cikin yara ƙwararru guda biyu. Arch Gen Zuciyar 1973; 28: 843-846. Duba m.
  55. Chadwick, D., Hallett, M., Harris, R., Jenner, P., Reynolds, EH, da Marsden, CD Clinical, biochemical, da kuma ilimin kimiyyar lissafi da ke rarrabe myoclonus mai amsa ga 5-hydroxytryptophan, tryptophan tare da mai hana monoamine oxidase, da clonazepam. Brain 1977; 100: 455-487. Duba m.
  56. Van Woert, M. H., Rosenbaum, D., Howieson, J., da Bowers, M. B., Jr. Magungunan dogon lokaci na myoclonus da sauran cututtukan jijiyoyin jiki tare da L-5- hydroxytryptophan da carbidopa. N Engl J Med 1-13-1977; 296: 70-75. Duba m.
  57. Nolen WA, van de Putte JJ, Dijken WA, Kamp JS. L-5HTP a cikin baƙin ciki mai juriya don sake hana masu hanawa. Binciken buɗewa tare da tranylcypromine. Br J Zuciyar 1985; 147: 16-22. Duba m.
  58. De Benedittis G, Massei R. Serotonin na gaba a cikin ciwon kai na farko. Nazarin makaho mai makafi biyu tare da L-5-hydroxytryptophan vs. placebo. J Neurosurg Sci 1985; 29: 239-48. Duba m.
  59. Titus F, Dávalos A, Alom J, Codina A. 5-Hydroxytryptophan a kan methysergide a cikin maganin cutar ƙaura. Gwajin gwaji da bazuwar. Eur Neurol 1986; 25: 327-9. Duba m.
  60. Santucci M, Cortelli P, Rossi PG, Baruzzi A, Sacquegna T. L-5-hydroxytryptophan a kan placebo a cikin ƙwayar ƙwayar ƙaura ta ƙuruciya: nazarin makafi biyu makaho. Cephalalgia 1986; 6: 155-7. Duba m.
  61. Irwin, M. R., Marder, S. R., Fuentenebro, F., da Yuwiler, A. L-5-hydroxytryptophan suna haɓaka alamun bayyanar cututtukan psychotic da D-amphetamine ya haifar. Ciwon ƙwayar cuta Res. 1987; 22: 283-289. Duba m.
  62. Angst J, Woggon B, Schoepf J. Maganin baƙin ciki tare da L-5-hydroxytryptophan da imipramine. Sakamako na buɗe biyu da ɗayan binciken makafi biyu. Arch Masanin Nervenkr 1977; 224: 175-86. Duba m.
  63. Kahn RS, Westenberg HG, Verhoeven WM, da sauransu. Tasirin abin da ke gaba na serotonin da mai hana shiga cikin rikicewar damuwa; kwatancen makafi biyu na 5-hydroxytryptophan, clomipramine da placebo. Int Clin Psychopharmacol 1987; 21: 33-45. Duba m.
  64. De Giorgis G, Miletto R, Iannuccelli M, Camuffo M, Scerni S. Ciwon kai tare da haɗuwa da rikicewar bacci a cikin yara: kimantawa game da ilimin halayyar kwakwalwa da nazarin asibiti - L-5-HTP da placebo. Magunguna Exp Clin Res Res 1987; 13: 425-33. Duba m.
  65. Zmilacher, K., Battegay, R., da Gastpar, M. L-5-hydroxytryptophan shi kaɗai kuma a haɗe tare da mai hana decarboxylase a cikin maganin ɓacin rai. Neuropsychobiology 1988; 20: 28-35. Duba m.
  66. Nolen, W. A., van de Putte, J. J., Dijken, W. A., Kamp, J. S., Blansjaar, B. A., Kramer, H.J, da Haffmans, J. Dabarar jiyya a ciki. II. MAO masu hanawa a cikin damuwa mai tsayayya da maganin antidepressants na cyclic: biyu ana gudanar da karatun ketarawa tare da tranylcypromine akan L-5-hydroxytryptophan da nomifensine. Dokar tabin hankali. Scand 1988; 78: 676-683. Duba m.
  67. Kaneko M, Kumashiro H, Takahashi Y, Hoshino Y. L-5HTP magani da magani na 5-HT bayan L-5-HTP da aka ɗora kan marasa lafiya. Neuropsychobiology 1979; 5: 232-40. Duba m.
  68. Rousseau JJ. Hanyoyin haɗakar levo-5-hydroxytryptophan-dihydroergocristine akan ɓacin rai da aikin neuropsychic: gwajin makafi mai saurin rufe wuribo mai sau biyu a cikin tsofaffi marasa lafiya. Clin Ther 1987; 9: 267-72. Duba m.
  69. Anders, T. F., Cann, H. M., Ciaranello, R. D., Barchas, J. D., da Berger, P. A. Furtherarin bayani game da amfani da 5-hydroxytryptophan a cikin yaron da ke fama da cutar Lesch-Nyhan. Neuropadiatrie. 1978; 9: 157-166. Duba m.
  70. Ceci F, Cangiano C, Cairella M, et al. Tasirin gudanarwar 5-hydroxytryptophan na baka akan halayyar ciyar da yara mata masu girma. J Tsarin Yanayi 1989; 76: 109-17. Duba m.
  71. Jangid P, Malik P, Singh P, Sharma M, Gulia AK. Nazarin kwatancen inganci na l-5-hydroxytryptophan da fluoxetine a cikin marasa lafiyar da ke gabatarwa tare da farkon ɓacin rai. Asiya J Zuciyar 2013; 6: 29-34. Duba m.
  72. Zarcone, V. P., Jr. da Hoddes, E. Hanyoyin 5-hydroxytryptophan akan rarrabuwa na REM barci a cikin masu shan giya. Am J Zuciya 1975; 132: 74-76. Duba m.
  73. Opladen, T., Hoffmann, G. F., da Blau, N. Binciken duniya game da marasa lafiya tare da rashi tetrahydrobiopterin da ke gabatar da hyperphenylalaninaemia. J heran gado. Mat Dis Dis 2012; 35: 963-973. Duba m.
  74. Baraldi, S., Hepgul, N., Mondelli, V., da Pariante, C. M. Magungunan cututtuka na cututtukan cututtukan ƙwayoyin cuta a cikin hepatitis C: nazari na yau da kullun. J Clin Psychopharmacol. 2012; 32: 531-543. Duba m.
  75. Pan, L., McKain, BW, Madan-Khetarpal, S., Mcguire, M., Diler, RS, Perel, JM, Vockley, J., da Brent, DA GTP-cyclohydrolase rashi mai amsa ga sapropterin da karin 5-HTP : sauƙin magani-ƙin baƙin ciki da halayyar kashe kansa. Halin BMJ.Rep. 2011; 2011 Duba m.
  76. Friedman, J., Roze, E., Abdenur, JE, Chang, R., Gasperini, S., Saletti, V., Wali, GM, Eiroa, H., Neville, B., Felice, A., Parascandalo, R., Zafeiriou, DI, Arrabal-Fernandez, L., Dill, P., Eichler, FS, Echenne, B., Gutierrez-Solana, LG, Hoffmann, GF, Hyland, K., Kusmierska, K., Tijssen, M.A., Lutz, T., Mazzuca, M., Penzien, J., Poll-The BT, Sykut-Cegielska, J., Szymanska, K., Thony, B., da Blau, N. Sepiapterin rashi raguwa: a mimic mai saurin magance cutar kwakwalwa. Ann Neurol. 2012; 71: 520-530. Duba m.
  77. Jukic T, Rojc B, Boben-Bardutzky D, Hafner M, Ihan A. Yin amfani da ƙarin abinci tare da D-phenylalanine, L-glutamine da L-5-hydroxytriptophan a cikin sauƙaƙe alamun maye na maye. Coll Antropol 2011; 35: 1225-30. Duba m.
  78. Sarris, J. Bacin rai na asibiti: ingantaccen tsarin bada magani wanda ya dace da tsarin magani. Madadin haka.Littafin Lafiya. 2011; 17: 26-37. Duba m.
  79. Dill, P., Wagner, M., Somerville, A., Thony, B., Blau, N., da Weber, P. neurowararren yara: ƙararrakin paroxysmal, kallon sama, da hypotonia: alamomin rashin ƙarancin sepiapterin. Neurology 1-31-2012; 78: e29-e32. Duba m.
  80. Horvath, GA, Selby, K., Poskitt, K., Hyland, K., Waters, PJ, Coulter-Mackie, M., and Stockler-Ipsiroglu, SG Hemiplegic migraine, kamuwa, ci gaba mai saurin motsa jiki, rikicewar yanayi, da coma a cikin 'yan uwan ​​da ke da ƙananan serotonin. Cephalalgia 2011; 31: 1580-1586. Duba m.
  81. Morrison, K. E. Tsarin jigilar kwayoyin halitta gaba daya yana ba da sanarwa game da magani: keɓaɓɓun magani yana ɗaukar wani mataki gaba. Clin Chem 2011; 57: 1638-1640. Duba m.
  82. Bainbridge, MN, Wiszniewski, W., Murdock, DR, Friedman, J., Gonzaga-Jauregui, C., Newsham, I., Reid, JG, Fink, JK, Morgan, MB, Gingras, MC, Muzny, DM, Hoang, LD, Yousaf, S., Lupski, JR, da Gibbs, RA Tsarin jigilar kwayar halitta don inganta kulawar haƙuri. Sci Transl.Med 6-15-2011; 3: 87re3. Duba m.
  83. den Boer JA, Westenberg HG. Havwararraki, neuroendocrine, da kuma ilmin kimiyar halittu na 5-hydroxytryptophan a cikin rikicewar tsoro. Maganin ƙwararraki Res 1990; 31: 267-78. Duba m.
  84. Adamsen, D., Meili, D., Blau, N., Thony, B., da Ramaekers, V. Autism hade da ƙananan 5-hydroxyindolacetic acid a cikin CSF da nau'in heterozygous SLC6A4 gene Gly56Ala da 5-HTTLPR L / L masu tallata nau'ikan . Tsarin Metab. 2011; 102: 368-373. Duba m.
  85. Cross, D. R., Kellermann, G., McKenzie, L. B., Purvis, K. B., Hill, G. J., da Huisman, H. Wani maganin amino acid da aka yi niyya ba tare da halayyar yara masu haɗari ba. Kula da lafiyar Yara Dev. 2011; 37: 671-678. Duba m.
  86. Gendle, M. H. da Golding, A. C. Gudanar da baki na 5-hydroxytryptophan (5-HTP) na gurgunta yanke shawara a cikin shubuha amma ba cikin haɗari ba: shaida daga kungiyar Caca ta Iowa. Hum Psychopharmacol. 2010; 25: 491-499. Duba m.
  87. Iovieno, N., Dalton, E. D., Fava, M., da Mischoulon, D. Magungunan antidepressants na ƙasa na biyu: nazari da suka. J Ya Shafar. 2011; 130: 343-357. Duba m.
  88. Leu-Semenescu, S., Arnulf, I., Decaix, C., Moussa, F., Clot, F., Boniol, C., Touitou, Y., Levy, R., Vidailhet, M., da Roze, E. Barci da kuma tasirin motsa jiki na asarar kwayar serotonin. Barci 3-1-2010; 33: 307-314. Duba m.
  89. Freedman RR. Jiyya zafi mai zafi na haila tare da 5-hydroxytryptophan. Maturitas 2010; 65: 383-5. Duba m.
  90. Makonni, B. S. Tsarin yau da kullun na abubuwan abincin da ake ci da tsire-tsire don nishaɗi da aikin damuwa: Relarian. Med Sci Monit. 2009; 15: RA256-RA262. Duba m.
  91. Rondanelli M, Klersy C, Iadarola P, et al. Bayanin haƙuri da amino-acid a cikin mata masu kiba bayan wani sabon magani da aka yi amfani da tsire-tsire mai ƙarancin tsire-tsire. Int J Obes (Lond) 2009; 33: 1174-1182. Duba m.
  92. Maissen CP, Ludin HP. [Kwatanta tasirin 5-hydroxytryptophan da propranolol a cikin tazarar maganin ƙaura]. Schweiz Med Wochenschr 1991; 121: 1585-90. Duba m.
  93. Shell W, Bullias D, Charuvastra E, et al. Gwaji, gwajin sarrafa wuribo na shirin amino acid akan lokaci da ingancin bacci. Am J Ther 2010; 17: 133-9. Duba m.
  94. Trujillo-Martin, M. M., Serrano-Aguilar, P., Monton-Alvarez, F., da Carrillo-Fumero, R. Inganci da amincin jiyya don lalata ataxias: nazari na yau da kullun. Rikicin Mov 6-15-2009; 24: 1111-1124. Duba m.
  95. Rothman, R. B. Jiyya na kiba tare da "haɗuwa" pharmacotherapy. Am J Ther 2010; 17: 596-603. Duba m.
  96. Chae, HS, Kang, OH, Choi, JG, Oh, YC, Lee, YS, Jang, HJ, Kim, JH, Park, H., Jung, KY, Sohn, DH, da Kwon, DY 5-hydroxytryptophan yana aiki akan Mitogen-activated protein kinase extracellular-siginar ta tsara hanyar gina jiki ta hanyar gina jiki don canza yanayin cyclooxygenase-2 da inducible nitric oxide synthase a cikin kwayoyin RAW 264.7. Biol Pharm Bull 2009; 32: 553-557. Duba m.
  97. Hendricks, E. J., Rothman, R. B., da Greenway, F. L. Ta yaya ƙwararrun likitocin kiba ke amfani da kwayoyi don magance kiba. Kiba. (Azurfa.Spring) 2009; 17: 1730-1735. Duba m.
  98. Longo, N. Rashin lafiya na maganin biopterin metabolism. J Gadon. Mizkab 2009; 32: 333-342. Duba m.
  99. Pons, R. Yanayin samfuran cututtukan cututtukan yara da ƙarancin yara. J Gadon. Mizkin Dis 2009; 32: 321-332. Duba m.
  100. Schaefer, M., Winterer, J., Sarkar, R., Uebelhack, R., Franke, L., Heinz, A., da Friebe, A. Abubuwa uku na cin nasara tryptophan add-on ko monotherapy na hepatitis C da IFNalpha -tattara yanayin yanayi. Psychosomatics 2008; 49: 442-446. Duba m.
  101. Jacobsen, JP, Nielsen, EO, Hummel, R., Redrobe, JP, Mirza, N., da Weikop, P. Rashin hankali na ƙwayoyin ƙwayoyin cuta na NMRI don zaɓin masu hana fitowar serotonin a cikin gwajin dakatar da wutsiya za a iya juyawa ta hanyar haɗin gwiwa tare da 5 -hydroxytryptophan. Psychopharmacology (Berl) 2008; 199: 137-150. Duba m.
  102. Liu, K. M., Liu, T. T., Lee, N. C., Cheng, L. Y., Hsiao, K. J., da Niu, D. M. Kulawa na dogon lokaci na marasa lafiyar Sinawa na kasar Sin da aka kula da su da wuri don rashi na 6-pyruvoyl-tetrahydropterin. Jirgin Neurol. 2008; 65: 387-392. Duba m.
  103. Horvath, GA, Stockler-Ipsiroglu, SG, Salvarinova-Zivkovic, R., Lillquist, YP, Connolly, M., Hyland, K., Blau, N., Rupar, T., da Ruwa, PJ Autosomal recessive GTP cyclohydrolase I rashi ba tare da hyperphenylalaninemia ba: shaidar ci gaba ta hanyar haɓaka tsakanin siffofin masu rinjaye da mawuyacin hali. Hanyar Hannu. 2008; 94: 127-131. Duba m.
  104. Morrow, J. D., Vikraman, S., Imeri, L., da Opp, M. R. Tasirin serotonergic kunnawa da 5-hydroxytryptophan akan bacci da zafin jiki na C57BL / 6J da kuma interleukin-6-rashi mice suna da kashi da lokaci. Barci 1-1-2008; 31: 21-33. Duba m.
  105. Meolie, AL, Rosen, C., Kristo, D., Kohrman, M., Gooneratne, N., Aguillard, RN, Fayle, R., Troell, R., Townsend, D., Claman, D., Hoban, T., da Mahowald, M. Maganin ba da magani ba na maganin rashin barci ba: kimantawa na samfuran tare da iyakantacciyar shaida. J Jima'i Bar Med Med 4-15-2005; 1: 173-187. Duba m.
  106. Cangiano C, Ceci F, Cairella M, et al. Hanyoyin 5-hydroxytryptophan akan halayyar cin abinci da bin bin umarnin abinci a cikin batutuwan manya. Adv Exp Med Biol 1991; 294: 591-3. Duba m.
  107. Petre-Quadens, O. da De Lee, C. 5-Hydroxytryptophan kuma suna barci a cikin ciwon Down. J Neurol Sci 1975; 26: 443-453. Duba m.
  108. Lesch, K. P., Hoh, A., Disselkamp-Tietze, J., Wiesmann, M., Osterheider, M., da Schulte, H. M. 5-Hydroxytryptamine1A mai karɓar rashi a cikin rikice-rikice-rikice-rikice. Kwatanta marasa lafiya da sarrafawa. Arch Gen Magunguna 1991; 48: 540-547. Duba m.
  109. Halladay, AK, Wagner, GC, Sekowski, A., Rothman, RB, Baumann, MH, da Fisher, H. Canje-canje a cikin shan barasa, kamuwa da cutar shan inna, da kuma yaduwar kwayar cutar ta monoamine a cikin berayen da aka yi amfani da su tare da phentermine da 5-hydroxy-L-tryptophan . Yanayin 2006; 59: 277-289. Duba m.
  110. Curcio, J. J., Kim, L. S., Wollner, D., da Pockaj, B. A. potentialarfin 5-hydryoxytryptophan don ragin filashi mai zafi: zance. Madadin Rev 2005; 10: 216-221. Duba m.
  111. Victor, S. da Ryan, S. W. Magunguna don hana ciwon kai na ƙaura a cikin yara. Cochrane Database. Syst. Rev 2003;: CD002761. Duba m.
  112. George DT, Lindquist T, Rawlings RR, et al. Magungunan magani na kaurace wa marasa lafiya da shan barasa: babu inganci na 5-hydroxytryptophan ko levodopa. Clin Pharmacol Ther 1992; 52: 553-60. Duba m.
  113. Shaw, K., Turner, J., da Del Mar, C. Tryptophan da 5-hydroxytryptophan don damuwa. Cochrane Database. Syst Rev 2002;: CD003198. Duba m.
  114. Ciaranello, R. D., Anders, T. F., Barchas, J. D., Berger, P. A., da Cann, H. M. Yin amfani da 5-hydroxytryptophan a cikin yaron da ke fama da cutar Lesch-Nyhan. Psywararrun Humwararrun yara Hum Dev 1976; 7: 127-133. Duba m.
  115. Anderson, L. T., Herrmann, L., da Dancis, J. Sakamakon L-5-hydroxytryptophan akan mutilatin kai tsaye a cutar Lesch-Nyhan: rahoto mara kyau. Neuropadiatrie. 1976; 7: 439-442. Duba m.
  116. Growdon, J. H., Young, R. R., da Shahani, B. T. L-5-hydroxytryptophan a cikin maganin wasu nau'ikan cuta daban-daban wanda myoclonus ya yi fice. Neurology 1976; 26: 1135-1140. Duba m.
  117. Takahashi S, Kondo H, Kato N. Sakamakon l-5-hydroxytryptophan a kan kwakwalwa monoamine metabolism da kimantawa na asibiti sakamako a cikin tawayar marasa lafiya. J Zuciyar Res 1975; 12: 177-87. Duba m.
  118. Preshaw RM, Leavitt D, Hoag G. Abincin mai cin abinci 5-hydroxytryptophan da urinary 5-hydroxyindole acetic acid. CMAJ 2008; 178: 993. Duba m.
  119. Byerley WF, Judd LL, Reimherr FW, Grosser BI. 5-Hydroxytryptophan: nazari game da ingancin antidepressant da illa mara kyau. J Clin Psychopharmacol 1987; 7: 127-37 .. Duba m.
  120. Shaw K, Turner J, Del Mar C. Tryptophan da 5-hydroxytryptophan don damuwa. Cochrane Database Syst Rev 2002;: CD003198. Duba m.
  121. Caruso I, Sarzi Puttini P, Cazzola M, Azzolini V. Nazarin makafi biyu na 5-hydroxytryptophan a kan placebo a cikin maganin cututtukan fibromyalgia na farko. J Int Med Res. 1990; 18: 201-9. Duba m.
  122. Johnson KL, Klarskov K, Benson LM, et al. Kasancewar gaban X da mahaɗan da suka danganci: gurɓataccen rahoton idan har ya shafi 5-hydroxy-L-tryptophan da ke da alaƙa da ciwon eosinophilia-myalgia. J Rheumatol 1999; 26: 2714-7. Duba m.
  123. Singhal AB, Caviness VS, Begleiter AF, et al. Cutar ƙwaƙwalwar kwakwalwa da bugun jini bayan amfani da magungunan serotonergic. Neurology 2002; 58: 130-3. Duba m.
  124. U. S. Gudanar da Abinci da Magunguna, Cibiyar Kula da Abincin da Abincin Abinci, Ofishin Kayan Abinci, Rubutawa, da Abincin Abincin. Takarda Bayani akan L-Tryptophan da 5-hydroxy-L-tryptophan, Fabrairu 2001.
  125. Nardini M, De Stefano R, Iannuccelli M, et al. Maganin baƙin ciki tare da L-5-hydroxytryptophan haɗe tare da chlorimipramine, binciken makafi biyu. Int J Clin Pharmacol Sakamakon 1983; 3: 239-50. Duba m.
  126. Ribeiro CA. L-5-Hydroxytryptophan a cikin prophylaxis na yawan tashin hankali-nau'in ciwon kai: mai makafi biyu, bazuwar, nazarin-wuribo. Ciwon kai 2000; 40: 451-6. Duba m.
  127. Poldinger W, Calanchini B, Schwarz W. Tsarin aiki-girma don rashin ciki: rashi serotonin azaman cutar ciwo a cikin kwatanta 5-hydroxytryptophan da fluvoxamine. Patwararren ilimin ilimin zuciya 1991; 24: 53-81. Duba m.
  128. Sternberg EM, Van Woert MH, Matasa SN, et al. Developmentaddamar da rashin lafiya mai kama da scleroderma yayin maganin tare da L-5-hydroxytryptophan da carbidopa. N Engl J Med 1980; 303: 782-7. Duba m.
  129. Cibiyar Abinci da Magunguna ta Amurka. Ba a tabbatar da ƙazanta a cikin kariyar abincin 5-hydroxy-L-tryptophan ba. Takardar Magana ta FDA, 31 ga Agusta, 1998; T98-48.
  130. Meyer JS, Welch KM, Deshmukh VD, et al. Neurotransmitter precursor amino acid a cikin maganin cututtukan mahaifa masu yawa da cutar Alzheimer. J Amer Geriat Soc 1977; 25: 289-98. Duba m.
  131. Trouillas P, Brudon F, Adeleine P. Inganta cerebellar ataxia tare da nau'in levorotatory na 5-hydroxytryptophan: nazari mai makafi biyu tare da adadin bayanan sarrafawa. Jirgin Neurol 1988; 45: 1217-22. Duba m.
  132. Kahn RS, Westenberg HG. L-5-hydroxytryptophan a cikin maganin rikicewar damuwa. J Cutar Cutar 1985; 8: 197-200. Duba m.
  133. Cangiano C, Ceci F, Cancino A, et al. Halin cin abinci da bin umarnin abinci na abinci a cikin manyan batutuwa masu girma waɗanda aka bi da su tare da 5-hydroxytryptophan. Am J Clin Nutr 1992; 56: 863-7. Duba m.
  134. Sarzi Puttini P, Caruso I. Ciwon fibromyalgia na farko da 5-hydroxy-L-tryptophan: nazarin buɗewar kwanaki 90. J Int Med Res 1992; 20: 182-9. Duba m.
  135. Nakajima T, Kudo Y, Kaneko Z. Gwajin asibiti na 5-hydroxy-L-tryptophan azaman maganin antidepressant. Folia Mashahuri Neurol Jpn 1978; 32: 223-30. Duba m.
  136. Michelson D, Shafin SW, Casey R, et al. Cutar rashin lafiyar eosinophilia-myalgia da ke da alaƙa da haɗuwa da L-5-hydroxytryptophan. J Rheumatol 1994; 21: 2261-5. Duba m.
  137. Birdsall TC. 5-Hydroxytryptophan: Aikin-Ingantaccen Serotonin Precursor. Madadin Rabaren 1998; 3: 271-80. Duba m.
Binciken na ƙarshe - 12/29/2020

Ya Tashi A Yau

Matananan hematoma
Magani

Matananan hematoma

Ciwon mara mai raɗaɗi hematoma wani "t ohuwar" tarin jini ne da abubuwan fa hewar jini t akanin fu kar kwakwalwa da kuma uturarta ta waje (dura). Mat ayi na yau da kullun na hematoma yana fa...
Cutar Parkinson
Magani

Cutar Parkinson

Cutar Parkin on (PD) wani nau'in cuta ne na mot i. Yana faruwa lokacin da kwayoyin jijiyoyi a cikin kwakwalwa ba a amarda i a hen inadarin kwakwalwa da ake kira dopamine. Wa u lokuta yakan zama kw...